NDRA logo

NDRA
ENDRA Life Sciences Inc

10,982
Mkt Cap
$4.05M
Volume
7,330.00
52W High
$11.96
52W Low
$2.90
PE Ratio
-0.26
NDRA Fundamentals
Price
$3.47
Prev Close
$3.27
Open
$3.32
50D MA
$4.01
Beta
1.40
Avg. Volume
259,051.69
EPS (Annual)
-$56.94
P/B
15.93
Rev/Employee
$0.00
$1.38
Loading...
Loading...
News
all
press releases
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its regulatory and commercial outlook.
Zacks·11d ago
News Placeholder
More News
News Placeholder
ENDRAs TAEUS Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced...
Business Wire·16d ago
News Placeholder
ENDRAs TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermo-acoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced new...
Business Wire·3mo ago
News Placeholder
ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction-associated liver disease...
Business Wire·4mo ago
News Placeholder
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease...
Business Wire·4mo ago
News Placeholder
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (MASLD) and...
Business Wire·4mo ago
News Placeholder
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (MASLD) and...
Business Wire·5mo ago
News Placeholder
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.
Zacks·5mo ago
News Placeholder
What’s Driving The Rally In NDRA Stock Today?
The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.
Stocktwits·5mo ago
News Placeholder
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.
Zacks·5mo ago
<
1
2
...
>

Latest NDRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.